Tuesday, August 21, 2012

OTCBB Tuesday Morning Movers; Beverage Stocks (OTCBB: ATTD), (OTCBB: AHFD) Make Top Volume Leaders List

New York, New York - August 21, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors reports on the top five volume traders on the OTCBB for Tuesday morning, August 21st.

Beverage stocks Attitude Drinks Inc (OTCBB: ATTD) and Active Health Foods Inc. (OTCBB: AHFD) make the list again, showing investor interest in microcap beverage stocks continues to remain high.
Mass Hysteria Entertainment Company Inc. (OTCBB: MHYS) leads the OTCBB volume leadears trading in a range of 0.0009 - 0.0010 on over 11 Million shares. Last week it reported it entered into a non-binding Memorandum of Understanding to acquire a real estate investment/development group which owns properties consisting of a 16 unit rental apartment building with adjacent land with planned use for a second apartment building and 12.4 acres of land for development located adjacent to a key highway intersection both located in Southern California.
Beverage stock Attitude Drinks Inc (OTCBB: ATTD) has traded over 9 Million shares at the time of this report. The stock has made the top volume leaders list frequently in the past few weeks.
Applied DNA Sciences Inc. (OTCBB: APDN) is down on over 6 Million shares following its run in the past few days. The stock had a morning range of $0.12 - 0.1595.
Beverage and health stock Active Health Foods Inc. (OTCBB: AHFD ) is up over 4% on just under 5 Million shares. This stock also makes the top volume leaders list frequently.
Internal Fixation Systems Inc. (OTCBB: IFIX) is trading down this morning on just under 3 Million shares.
About OTCBB
http://www.otcbb.com/
Research beverage stocks with the beverage stocks directory at Investorideas.com
http://www.investorideas.com/Beverage_Stocks/Stock_List.asp
Featured Beverage Stock
DC Brands International (OTC: HRDN) specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category.
In June Mr. Stephen Horgan, Brand Aspirations Founder and Former Coca-Cola (NYSE:KO) and Coors Veteran purchased controlling interest of DC Brands International, Inc. (OTC: HRDN) /dba/H.A.R.D. Nutrition and is now acting President and CEO of the Company.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
DC Brands is featured on Running Bull OTC for SMS alerts - Sign up now!
http://www.runningbullotc.com/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com 800 665 0411

Biotech Stock News Alert; Aethlon Medical (OTCBB: AEMD) Announces Renewal of DARPA Dialysis-Like Therapeutics Contract

SAN DIEGO - August 21, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the Defense Advanced Research Projects Agency (DARPA) has exercised an option agreement to proceed with year-two of a five-year $6.8 million contract that was awarded to Aethlon on September 30, 2011 under DARPA's Dialysis-Like Therapeutics (DLT) program.

As a result, Aethlon is able to initiate work toward year-two contract milestones ahead of the schedule. The second year of Aethlon's DLT contract contains eight milestones representing a potential of $1,617,446 in revenue opportunity. To date, Aethlon has invoiced $1,758,300 to DARPA for achieving seven of eight milestone objectives targeted in year-one of the DLT program. Aethlon further disclosed that it has completed its eighth year-one milestone objective worth $216,747, but has not yet invoiced DARPA.
The Company also disclosed that it has teamed with two larger organizations in response to a follow-on DLT contract opportunity entitled DARPA BAA-12-36. The announcement of DARPA BAA-12-36 contract awards is anticipated later this fall.
The goal of the DLT program is to develop a portable device that removes "dirty" blood from the body, separates harmful agents, and returns "clean" blood to the body in a manner similar to dialysis treatment of kidney failure. The resulting device would decrease the morbidity and mortality of sepsis, thereby saving thousands of lives and billions of dollars in the United States annually. In the DLT program, Aethlon has been contracted to utilize the Aethlon ADAPT™ system to create an extracorporeal blood purification cartridge that selectively eliminates sepsis-enabling particles from circulation to promote recovery and prevent sepsis. The Aethlon ADAPT™ converges advanced plasma membrane technology with high affinity drug agents to allow the selective yet rapid clearance of disease targets from the entire circulatory system without damaging blood cells or removing particles essential for health. Aethlon has also been contracted to develop a novel blood circulatory instrument that will deliver ADAPT™ based and other therapeutic filtration devices without systemic anticoagulants normally required in extracorporeal therapies.
Beyond the civilian need for anti-sepsis therapies, the device proposed in the DLT program would play an important role in saving the lives of wounded U.S. military personnel, as infection leading to sepsis is a significant cause of mortality. When sepsis is complicated by shock, approximately half of patients do not survive for 30 days, even if effective antibiotics are used. Unfortunately, the fatality rate from sepsis can be high, given that antibiotic-resistant bacteria are an increasing problem for injured warfighters and military treatment facilities. Bio-agents engineered for resistance against antibiotics also represent a significant threat to both warfighters and citizens. Current culture-based methods of identifying blood-borne pathogens can take 48 hours or longer to identify the offending pathogen, and some blood-borne pathogens do not propagate in culture. Pending these culture results, septic patients are treated with protocol-based broad-spectrum antibiotics. In the event the offending pathogen is resistant to the empirically chosen antibiotic, the fatality rate may increase as much as 9% per hour.
Investorideas.com Newswire
About Aethlon Medical
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company's clinical programs or provide market clearance of the company's products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page on Investorideas.comDisclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) Investorideas.com is paid by AEMD to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs

Monday, August 20, 2012

Healthcare Stock News: Comprehensive Care Corporation (OTCBB: CHCR) Names Jairo Estrada Senior Management Advisor To Assist in Growing the Company's New Pharmacy Initiatives

TAMPA, Fla. - August 20, 2012 (Investorideas.com newswire) Comprehensive Care Corporation ("CompCare" or the "Company") (OTCBB: CHCR), which provides behavioral health, substance abuse and psychotropic pharmacy management services, is pleased to announce that it has appointed Jairo A. Estrada, who was instrumental in growing a gardening and yard care company from $7 million to $400 million. Mr. Estrada will advise senior management in implementing a plan designed to increase the Company's revenue and assist in the marketing of its innovative pharmacy cost-containment program.

Clark A. Marcus, Chairman and CEO said, "On behalf of senior management, I would like to express how excited and pleased we are to add Mr. Estrada, a highly regarded senior executive, to the CompCare team. Mr. Estrada's career achievements are nothing short of remarkable. We believe his business acumen and proven capabilities in generating substantial corporate growth will be of great benefit to the Company. I look forward to the Company's continued progression with the help of Mr. Estrada's knowledge and guidance."
Mr. Estrada was named President and Chief Operating officer of Garden Way Inc. in 1984 and subsequently became Chairman and CEO. The Company produced and marketed a wide range of well known outdoor power equipment, including the TROY-BILT® Roto Tiller and the BOLENS® Tractor. He assisted in developing a multi-channel distribution system to increase company revenues.
Mr. Estrada was also instrumental in the acquisition by Garden Way of StairMaster Sports/Medical Products, Inc., a major worldwide designer and manufacturer or therapeutic exercise equipment, and five other businesses, to exponentially increase the company's revenues.
As CEO, Mr. Estrada also guided one of the first U.S. companies to penetrate the Chinese market and sell products in the world's most populous nation. He also serves as Chairman of a manufacturing company servicing the pharmaceutical industry in Puerto Rico.
Mr. Estrada received a Bachelor's Degree in Economics and in Business Administration, and a Master's Degree in Organizational Behavioral Sciences from SUNY at Buffalo, New York. He has served on the Board of Directors of numerous companies, including the leading telecommunications company in Puerto Rico; the Chase Manhattan Bank Board of Directors and its Executive Committee, and Global Crossing.
"In a sector where costs continue to rise, I was intrigued by CompCare's recent pharmaceutical initiative, a service with the potential to significantly reduce costs for corporations, as well as the success Clark Marcus and his team have already accomplished. I am eager to work with CompCare's team and confident that I can contribute to the Company increasing its share of the pharmacy management market and an even greater level of corporate success in its healthcare initiatives," said Mr. Estrada.
About CompCare:
Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond CompCare's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, the ability of CompCare to maximize its market share with new pharmacy initiatives, the ability of CompCare and its staff to execute its business plan, the ability of CompCare to offer and sell any of its products at a profit, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability, if any, of our capitated contracts or other products, increases or variations in cost of care, seasonality, CompCare's ability to obtain additional financing, increased outsourcing of behavioral health services, and additional risk factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Any forward- looking statement in this release speaks only as of the date on which it is made. CompCare assumes no obligation to update or revise any forward-looking statements.
Published at Investorideas.com Newswire
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: Investorideas.com is compensated for publishing and distributing news for CHCR: four thousand for one month by third party IR firm
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Sunshine Biopharma (OTCBB: SBFM) Management Bets on Lead Anti-Cancer Compound Adva-27a; Taking No Compensation

New York, New York - August 20, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks releases an investor alert on Sunshine Biopharma Inc. (OTCBB: SBFM) reporting on management's unusual commitment to the shareholders; no compensation is currently paid out to the top executives according to Company filings.

Key management including Chairman and CEO, Dr. Steve N. Slilaty Ph.D, Mr. Camille Sebaaly, CFO and Mr. Michele Di Turi, COO do own equity in the company.
Sunshine Biopharma's lead compound, Adva-27a is an effective and highly specific Topoisomerase II (Top2) Inhibitor that has proven effective at killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR).
The Company recently reported that it has submitted a manuscript detailing Adva-27a preclinical research results for publication in a peer-reviewed scientific journal. Adva-27a is Sunshine Biopharma's lead anti-cancer compound which has been shown to be effective at killing multidrug resistant cancer cells in vitro. Multidrug resistant cancer cells do not respond to any of the chemotherapy drugs currently in use for cancer treatment. The manuscript, which was prepared by Sunshine Biopharma scientists in collaboration with scientists from Binghamton University in New York and from Ecole Polytechnique in Montreal ( Canada), contains a substantial amount of data compiled from experiments conducted by these scientists.
Read Investorideas.com Q&A Interview with Mr. Camille Sebaaly, CFO
http://www.investorideas.com/CO/SBFM/news/2012/07021.asp
SEC filings: http://finance.yahoo.com/q/sec?s=SBFM+SEC+Filings
About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer.
www.sunshinebiopharma.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas: www.biotechindustrystocks.com
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and biotech stock alerts
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated Investorideas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Friday, August 17, 2012

Microcap Beverage Stocks to Watch: (OTC: ATTD), (OTC: BBDA), (OTC: HRDN), (OTC: HBRM)

New York, New York - August 17, 2012 (Investorideas.com Newswire, www.beveragestocks.com) - Investorideas.com, an investor research portal specializing in sector research including beverage stocks issues an alert for actively traded beverage stocks for August 17th.

Herborium Group, Inc. (OTC: HBRM) is up 42.5%, trading at 0.0017 as of 2:15PM EDT. The Company reported news earlier this week “distribution of Kamasutra™ Exotic Vodka with herbal formula provided by Herborium, a pioneering specialty drink now available for the first time in the US, has officially started with a first wholesale order of 1000 cases.”
Bebida Beverage Company (OTCBB: BBDA) is by far one of the most actively traded beverage stocks on the OTC, currently at 0.0170, down 0.0012(6.59%) 2:16PM EDT on over 81 Million shares.
DC Brands International Inc. (OTC: HRDN) is trading down with a day's range of 0.0035 - 0.0043 on over 500,000 shares. The stock has had some big percentage gains in earlier trading this week.
Attitude Drinks Incorporated (OTC BB: ATTD) is flat but trading big volume, currently at $0.0006 as of 2:09PM EDT on over 14.6 Million shares.
Research beverage stocks with the beverage stocks directory at Investorideas.com - one of the largest beverage stock directories online
http://www.investorideas.com/Beverage_Stocks/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
DC Brands is featured on Running Bull OTC for SMS alerts - Sign up now for the Ap - now available for Android and iphone and Blackberry coming soon,
http://www.runningbullotc.com/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand  
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com 800 665 0411

TSX Mining Stock Alert: SilverCrest Mines (TSX-V: SVL) Moves Following Financial Results

New York, New York - August 17, 2012 (Investorideas.com Mining Stocks Newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors including mining stocks, issues a trading alert and stock chart for SilverCrest Mines Inc. (TSX-V:SVL)(OTCQX:STVZF).
The Company reported its financial results for the second quarter ended June 30, 2012 on Wednesday of this week. The stock moved from the $2.05- $2.10 level to trading as high as $2.49 today.
The stock is currently trading at $2.45, up 0.08(3.38%) 1:24PM EDT on over 368,000 shares.
Investorideas.com Mining Newswire HIGHLIGHTS OF Q2, 2012 (Compared to Q2, 2011):
Cash flow from operations (1) increased 148% to $7.2 million.
Cash operating cost per silver equivalent ounce sold (2) decreased 16% to $6.94.
Revenues reported - IFRS (3) rose 87% to $16.0 million on sales of 124,739 silver ounces and 8,679 gold ounces.

Comprehensive earnings amounted to $9.2 million ($0.10 ps), compared to $0.8 million ($0.01 ps).
Working capital increased 64% to $29.6 million, up from $18.0 million.
Cash and cash equivalents were $34.9 million (at June 30, 2012).
(All figures in U.S. dollars unless otherwise specified)
Full News:
http://www.investorideas.com/CO/ SVL/news/ 2012/08151.asp
SilverCrest Mines Inc. (TSX-V: SVL) (OTCQX: STVZF) operates in Mexico and is a low cost precious metals producer with its headquarters based in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, which is located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag: Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango, Mexico.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer: Investorideas.com does not make stock recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Silvercrest Mines has compensated Investorideas for annual news publication and distribution and company profile: nine thousand seven hundred starting August 2012
More info: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com - 800 665 -0411

Ford (NYSE:F) Invests in Electric Vehicle Market Division; Bodes well for future for electric car stocks

New York, NY - August 17, 2012 (Investorideas.com newswire renewable energy/ green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an alert for electric car stocks following news this week from Ford (NYSE: F), that they are doubling their battery-testing capabilities and speeding electrified vehicles to market by at least 25 percent.

Ford also reported "The company now has more than 1,000 engineers working on electrification - its highest number ever."
The Company is putting its money where its mouth is betting on the electric car division.
Ford is investing $135 million in the design, engineering and production of key components - including advanced battery systems - for its next-generation hybrid-electric vehicles going into production this year.
Also, Ford is dedicating a 285,000-square-foot research and development lab in Dearborn, Mich., to focus almost entirely on hybrids and electrification. The building formerly known as the Advanced Engineering Center is renamed the Ford Advanced Electrification Center and houses most of the 1,000 engineers working on hybrid and electrification programs.
The stock is trading at $9.64, up 0.05(0.54%) 12:03PM EDT on over 17 Million shares with a high of $9.78. The 52 week range for the stock is $8.82 - 13.05.
Investorideas.com Newswire About Ford Motor Company
Ford Motor Company (NYSE: F), a global automotive industry leader based in Dearborn, Mich., manufactures or distributes automobiles across six continents. With about 168,000 employees and about 65 plants worldwide, the company's automotive brands include Ford and Lincoln. The company provides financial services through Ford Motor Credit Company. For more information regarding Ford and its products worldwide, please visit http://corporate.ford.com.
Research more cleantech stocks including electric car stocks - access 1400 green stocks at the Investorideas.com renewable energy stocks directory
Investorideas.com renewable energy stocks stock directory
About Investorideas.com - a leader in cleantech investor research
www.Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research tech stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks and more
Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411

Water Stocks Sector Snapshot: MWA, PHO, WTR

New York, New York - August 17, 2012 (Investorideas.com newswire, www.water-stocks.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors reports on water stocks trading for August 17th.

A report from the Civil Society Institute (http://www.CivilSocietyInstitute.org) just released found that “concerns about drought go hand in hand with worries about water shortages and also how to avoid making them worse. Three out of four Americans – including 61 percent of Republicans, 84 percent of Democrats and 80 percent of Independents -- think that "with all the current concern about severe drought and the risk of water shortages, America needs to start focusing more on alternative energy sources, such as wind and solar, that require less water." This view is shared consistently across nearly all drought-stricken states surveyed.”
As concerns mount several of the stocks are trading near or at 52 week highs.
Aqua America Inc. (NYSE:WTR) is trading up at $25.31, up 0.10 or 0.40% as of 11:39AM EDT on over 190,000 shares. The 52 week range for the stock is $20.16 - 26.93.
Mueller Water Products, Inc. (NYSE:MWA) is up 5.01%, trading at $4.19, gaining 0.20 as of 11:43AM EDT on 688,000 shares. The stock broke through its 52 week high today in trading.
Investorideas.com Newswire Water ETF PowerShares Water Resources (NYSEArca PHO) is trading up at 19.22, gaining 0.02 or 0.11% as of 11:26AM EDT. The 52 week range is 14.01 - 19.59.
Research water stocks with the water stocks directory at Investorideas.com
http://www.investorideas.com/Water-Stocks/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Full report on water shortages survey - http://www.investorideas.com/news/2012/water/08162.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Thursday, August 16, 2012

Biodefense Stock Trading Alert: PositiveID (OTCBB: PSID) Trading up 9.33%

New York, NY - August 16, 2012 - (Investorideas.com Newswire, www.biodefensestocks.com) Investorideas.com, a leader in research for independent investors issues a trading alert for biodefense stock, PositiveID Corporation (OTCBB: PSID), trading up over 9% on the day on volume of just under 800,000 at the time of this report. The stock is trading at $0.0164, up 0.0014 or 9.33% as of 1:05PM EDT, with a high of $0.0175.
Yesterday, PositiveID's Chairman and CEO William J. Caragol discussed the $5.7 Billion BioWatch Opportunity in an audio interview with SmallCapVoice.com. http://finance.yahoo.com/news/ positiveids-chairman-ceo- william-j-120000295.html
Investorideas.com Newswire About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.www.PositiveIDCorp.com.
About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, biodefense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com:
Contact: 800 665 0411

Homebuilder Stocks Trading Up: Builder Confidence Grows Reports NAHB

New York, NY - August 16, 2012 (Investorideas.com newswire, www.homebuilderstocks.com) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including homebuilder stocks issues a news and trading alert for the sector. Stocks are trading up today following yesterday’s report from the NAHB.

The SPDR S&P Homebuilders Index (NYSEArca: XHB) is at $22.73, up 0.36(1.60%) as of 11:43AM EDT.
Beazer Homes USA Inc. (NYSE:BZH) is up a notable 5.54% , trading at $2.86, moving 0.15 on over 3.7 Million shares as of 11:54AM EDT.
KB Home (NYSE:KBH) is up, trading at $10.69, gaining 0.37 or (3.59%) as of 11:46AM EDT. The stock has a 52-week range of $5.02 - 13.12.
Toll Brothers Inc. (NYSE:TOL) is up 2.3%, trading up at $31.16, gaining 0.70 as of 11:52AM EDT on over 700,000 shares.
PulteGroup, Inc. (NYSE:PHM) is in the green trading at $13.37, up 0.59(4.62%) 11:48AM EDT.
Investorideas.com Newswire NAHB Reports: Builder Confidence Continues To Improve in August
- Builder confidence in the market for newly built, single-family homes improved for a fourth consecutive month in August with a two-point gain to 37 on the National Association of Home Builders/Wells Fargo Housing Market Index (HMI), released today. This gain builds on a six-point increase in July and brings the index to its highest level since February of 2007.
"From the builder's perspective, current sales conditions, sales prospects for the next six months and traffic of prospective buyers are all better than they have been in more than five years," said Barry Rutenberg, chairman of the National Association of Home Builders (NAHB) and a home builder from Gainesville, Fla. "While there is still much room for improvement, we have come a long way from the depths of the recession and the outlook appears to be brightening."
"This fourth consecutive increase in builder confidence provides further evidence of the gradual strengthening that's occurring in many housing markets and providing a needed boost to local economies," said NAHB Chief Economist David Crowe. "However, we are still at a very fragile stage of this process and builders continue to express frustration regarding the inventory of distressed properties, inaccurate appraisal values, and the difficulty of accessing credit for both building and buying homes."
Derived from a monthly survey that NAHB has been conducting for the past 25 years, the NAHB/Wells Fargo Housing Market Index gauges builder perceptions of current single-family home sales and sales expectations for the next six months as "good," "fair" or "poor." The survey also asks builders to rate traffic of prospective buyers as "high to very high," "average" or "low to very low." Scores from each component are then used to calculate a seasonally adjusted index where any number over 50 indicates that more builders view sales conditions as good than poor.
Every HMI component posted gains in August. The components gauging current sales conditions and traffic of prospective buyers each rose three points, to 39 and 31, respectively, while the component gauging sales expectations in the next six months inched up one point to 44. All were at their highest levels in more than five years.
Regionally, builder confidence rose nine points to 42 in the Midwest and two points to 35 in the South, but declined nine points to 25 in the Northeast and three points to 40 in the West in August. For the August HMI release, NAHB is introducing an alternative trend comparison of regional HMIs by also showing a three-month moving average of each region's index. The current three-month moving averages show a two-point decline to 29 in the Northeast, a five-point gain to 35 in the Midwest, a three-point gain to 32 in the South and a three-point gain to 38 in the West.
http://www.nahb.org/news_details.aspx?newsID=15478
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including homebuilder stocks, beverage stocks, water stocks, biotech stocks and more.
Research homebuilder stocks at the Investorideas.com stock directory:
http://www.investorideas.com/Companies/HomebuilderStocks/HomebuilderStockList.asp
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Healthier, Natural Energy Drinks Expand the Demographics Beyond the 18- 30 Consumers and Lead the Sector's Growth Moving Forward

New York, NY - August 16, 2012 (Investorideas.com newswire, www.beveragestocks.com) Investorideas.com, an investor research portal specializing in sector research including beverage stocks issues an industry trend update on how the functional beverage market is changing to meet consumer preference for healthier, more natural energy drinks. This trend has increased sales in the energy drink sector and analysts and industry leaders predict it is a trend that will continue and shape the future of the beverage market.

As healthier lines come to market it expands the opportunity for the sector, reaching a new group of older consumers beyond the current 18- 30 demographics. What is more noteworthy is that this sector of the beverage industry started a break- out trend following 2008-2009 recession, showing growth and a new trend developing by 2010.
According to Packaged Facts research "by 2010 energy drinks/shots, sports drinks, RTD teas, and fruit/vegetable smoothies all showed renewed dynamism, signaling the onset of a new cycle of sales growth for the market. All had gains of at least 5%, with energy drinks/shots experiencing the highest gain at 10%. Sports drinks and RTD teas finished with gains of 8% and 7%, respectively."
Sensient Technologies Corporation (NYSE:SXT) food and beverage division is participating in the trend with its natural colors and flavors products.
In an interview earlier this year with FoodBev.com, Kenneth Manning, Chairman, President and CEO of Sensient noted "I see more vitamin-enriched beverages and more nutraceutical drinks in general. In particular I see growth in those targeting older consumers, plus beauty and health drinks targeting all ages.
I believe we will see an increase in the range of still drinks more than carbonated soft drinks.
The market has already seen many products which incorporate energy inducing characteristics as well as vitamin enrichment and other additives to promote various enhancements. Sensient sees this trend continuing and developing further into an array of ‘lifestyle' beverages attracting the consumer with additional functional characteristics that promote health or cosmetic benefits."
Starbucks (NASDAQ:SBUX) has joined the energy drink market with a line called " Refreshers" with Cool Lime and Very Berry Hibiscus using green coffee extract as one of the ingredients .
Like any industry, within the beverage industry sometimes it's the small niche players that are ahead of the curve. DC Brands International (OTC: HRDN) specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category.
In a recent interview, Stephen F. Horgan, CEO noted "The total non alcohol beverage market is over $110 Billion dollars in the US. Functional Beverages are approaching $15 Billion of that total. Our history is in nutritional supplements, which is where everything with our products emanates from. With the development of our proprietary flip-top cap delivery system, we were able to cross over into certain beverage occasions of nutrition conscious consumers. Our supplements provide a variety of solutions for these consumers looking for optimal nutrition delivery versus the minimal daily requirements. This is the case both with our dry line as well as our beverage line.
In June Mr. Stephen Horgan, Brand Aspirations Founder and Former Coca-Cola (NYSE:KO) and Coors Veteran purchased controlling interest of DC Brands International, Inc. (OTC: HRDN) /dba/H.A.R.D. Nutrition and is now acting President and CEO of the Company.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Research beverage stocks with the beverage stocks directory at Investorideas.com - one of the largest beverage stock directories online
http://www.investorideas.com/Beverage_Stocks/Stock_List.asp
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
DC Brands is featured on Running Bull OTC for SMS alerts - Sign up now and download the Ap to your phone for stock alerts and news
http://www.runningbullotc.com/
Sources:
http://www.sensient-tech.com/pdf/Beverage%20Innovation.pdf
Disclaimer/ Disclosure : The Investorideas.com wire is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand  
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investment involves risk and potential loss of all investment
Contact Investorideas.com: 800 665 0411

Wednesday, August 15, 2012

Biotech Stock Trading Alert: Sunshine Biopharma (OTCBB: SBFM) Moves 31% on News of Lead Anti-Cancer Compound Adva-27a Manuscript Publication

New York, New York - August 15, 2012 (Investorideas.com Newswire, Biotechindustrystocks.com) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Sunshine Biopharma Inc. (OTCBB:SBFM) following news of its lead anti cancer compound, Adva-27a Manuscript for "PUBLICATION IN A PEER-REVIEWED SCIENTIFIC JOURNAL."

The stock has moved 31% on the news at the time of this report.
The Company reported today that it has submitted a manuscript detailing Adva-27a preclinical research results for publication in a peer-reviewed scientific journal. Adva-27a is Sunshine Biopharma’s lead anti-cancer compound which has been shown to be effective at killing multidrug resistant cancer cells in vitro. Multidrug resistant cancer cells do not respond to any of the chemotherapy drugs currently in use for cancer treatment.
Full news release:
http://www.investorideas.com/CO/SBFM/ news/ 2012/08152.asp
Investorideas.com Newswire About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company’s lead compound, Adva-27a targets aggressive forms of cancer.
www.sunshinebiopharma.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas: www.biotechindustrystocks.com
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and biotech stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated Investorideas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Biodefense Stock News; PositiveID's (OTCBB: PSID) Chairman and CEO William J. Caragol Discusses $5.7 Billion BioWatch Opportunity with SmallCapVoice.com

AUSTIN, Texas - August 15, 2012 - (Investorideas.com Newswire) SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation (OTCBB: PSID), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for diabetes management, is now available. The interview can be heard at http://smallcapvoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
Statements about PositiveID's future expectations, including the likelihood that PositiveID's M-BAND is one of the only technologies capable of addressing the requirements of the BioWatch procurement; the likelihood that M-BAND was designed with a high level of operational flexibility; the likelihood that PositiveID is well positioned to compete for Generation 3 of the BioWatch program and the Company continues to work toward the expected deployment of its bioaerosol detectors; the likelihood that the Company's M-BAND has numerous technology advantages; the likelihood that the value of the BioWatch procurement is estimated at $5.7 billion; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize its bio-threat detection systems for homeland defense, including its M-BAND system; the likelihood that the Company will participate in the BioWatch program; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 28, 2012, and 10-Qs filed on May 14, 2012, November 14, 2011, and August 15, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
About PositiveID Corporation OTCBB:PSID)
PositiveID Corporation is an emerging growth developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense industry. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Trilogy Capital Partners, Inc.
Darren Minton, President
Toll-free: 800-592-6067
info@trilogy-capital.com
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and  company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

BI0PHARMA STOCK ALERT: SUNSHINE BIOPHARMA (OTCBB: SBFM) REPORTS SUBMISSION OF AN Adva-27a MANUSCRIPT FOR PUBLICATION IN A PEER-REVIEWED SCIENTIFIC JOURNAL

Montreal, Quebec, Canada - August 15, 2012 (Investorideas.com Newswire) Sunshine Biopharma Inc. (OTCBB:SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has submitted a manuscript detailing Adva-27a preclinical research results for publication in a peer-reviewed scientific journal. Adva-27a is Sunshine Biopharma’s lead anti-cancer compound which has been shown to be effective at killing multidrug resistant cancer cells in vitro. Multidrug resistant cancer cells do not respond to any of the chemotherapy drugs currently in use for cancer treatment.

The manuscript, which was prepared by Sunshine Biopharma scientists in collaboration with scientists from Binghamton University in New York and from Ecole Polytechnique in Montreal ( Canada), contains a substantial amount of data compiled from experiments conducted by these scientists.
About Sunshine Biopharma Inc. ( OTCBB: SBFM ):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company’s lead compound, Adva-27a targets aggressive forms of cancer.
www.sunshinebiopharma.com
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Recent Q&A with Mr. Camille Sebaaly, CFO of Sunshine Biopharma Inc. ( OTCBB: SBFM ) at Investorideas.com
http://www.investorideas.com/CO/SBFM/news/2012/07021.asp
Recent CFA commentary:
http://www.investorideas.com/CO/SBFM/news/2012/07301.asp
Published at Investorideas.com Newswire
Visit the biotech portal within Investor Ideas: www.biotechindustrystocks.com
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news and biotech stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated Investorideas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 www.Investorideas.com

Mining Stock News: SilverCrest (TSX.V: SVL) Reports Q2, 2012 Financial Results

VANCOUVER, BRITISH COLUMBIA - August 15, 2012 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX-V:SVL)(OTC.BB:STVZF) (the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2012 (all figures in U.S. dollars unless otherwise specified). HIGHLIGHTS OF Q2, 2012 (Compared to Q2, 2011):

  • Cash flow from operations (1)increased 148% to $7.2 million.
  • Cash operating cost per silver equivalent ounce sold (2)decreased 16% to $6.94.
  • Revenues reported - IFRS (3)rose 87% to $16.0 million on sales of 124,739 silver ounces and 8,679 gold ounces.
  • Comprehensive earnings amounted to $9.2 million ($0.10 ps), compared to $0.8 million ($0.01 ps).
  • Working capital increased 64% to $29.6 million, up from $18.0 million.
  • Cash and cash equivalents were $34.9 million (at June 30, 2012).
J. Scott Drever, President stated; "We had a strong second quarter of 2012. We sold 637,050 silver equivalent ounces (2), for gross revenues of $16.0 million, with an average cash operating cost of $6.94 per silver equivalent ounce. The Santa Elena low cost, open pit heap leach mine operations continue to perform well and generated cash flows of $7.2 million which will contribute to the financing of the Santa Elena Expansion plan and the development of our major polymetallic La Joya Project. Q2, 2012, production was consistent with our budget and cash operating costs were below our budget of $8.20 per silver equivalent ounce. As a result, we are confident in meeting or exceeding our 2012 production guidance of 435,000 silver ounces and 33,000 gold ounces."
Investorideas.com Mining Newswire
(1) Cash flow from operations before changes in working capital items.
(2) This is a Non-IFRS performance measure. Silver equivalent ounces consist of the number of ounces of silver production plus the number of ounces of gold production multiplied by the ratio of the spot gold price to the spot silver price at the quarter end dates. There are variances in produced and sold ounces due to carry forward inventories from previous quarter.
(3) Per "IFRS 18 - Revenue", revenue should be recorded at its fair value, which for gold and silver is the market spot price on the date revenue is recognized.
Comparison of Q2, 2012, to Q2, 2011
Comprehensive earnings were $9.2 million ($0.10 per share) compared with $0.8 million ($0.01 per share) for the same period in 2011. The significant increase in comprehensive earnings was largely driven by higher silver and gold sales volumes and a positive marked-to-market derivative impact, partially offset by lower realized silver and gold prices, increases in income and deferred tax expense and a larger exchange loss on translation to US Dollars.
In the second quarter 2012, silver and gold revenues totaled $16.0 million (2011 - $8.6 million), up 87% compared to the same quarter in 2011. Silver and gold revenues include $12.6 million (2011 - $6.2 million) earned on a cash basis and $2.7 million (2011 - $2.0 million) of non-cash revenues due to adjustments to gold spot market prices related to hedge facility deliveries and $0.7 million (2011 - $0.3 million) related to amortization of deferred revenues associated with the Sandstorm Agreement.
Silver sales were 124,739 ounces (2011 - 70,326) at an average realized price of $29 (2011 - $39). All silver production is unencumbered by hedging arrangements and sold at spot prices.
Gold sales were 8,679 ounces (2011 - 4,300). The Company sold 2,734 gold ounces (2011 - Nil) at market spot realized price of $1,649 (2011 - $Nil) per ounce. Gold delivered into the Hedging Facility was 4,210 ounces (2011 - 3,440) at an average realized price of $925 (2011 - $926). The non cash amount reported of $2.7 million (2011 - $2.0 million) represents the difference between the market spot price at the date of delivery for gold (at an average realized price of $1,574 (2011 - $1,510) per ounce) and the hedge price of $926.50 per ounce settled. This non-cash revenue reported is required by IFRS accounting policies. Gold delivered to Sandstorm was 1,735 ounces (2011 - 860) at an average realized gold price of $725 (2011 - $725) for which the Company recorded revenues of $1.3 million (2011 - $0.6 million) consisting of $0.6 million (2011 - $0.3 million) in cash received and $0.7 million (2011 - $0.3 million) from amortization of deferred revenue.
Cost of sales amounted to $4.4 million (2011 - $2.1 million). Cash cost per silver equivalent ounce sold amounted to $6.94 (2011 - $8.27). The decrease in cash cost per silver equivalent ounce over the same period in prior year reflects a significant increase in production volumes, crusher throughput and gold to silver ratio.
Under IFRS the Company's derivative instruments are fair valued at the financial position date, with the resulting gain or losses included in the operating results for the period. The derivative gain (loss) relates to the incremental fair value of the MBL Hedging Facility, which represents the difference between the market spot price of gold at the quarter end and strike price of $926.50 per ounce. Gain (loss) on derivative instruments during the period amounted to $2.4 million (2011 - ($3.5 million)) resulting from a change at the quarter end to $1,606 (2011 - $1,518) in the gold forward price from $1,671 (2011 - $1,456) in the previous quarter.
Comparison of Q2, 2012, to Q1, 2012
Comprehensive earnings were up 44% to $9.2 million ($0.10 per share), from $6.3 million ($0.07 per share). The increase in comprehensive earnings was largely driven by a positive marked-to-market derivative impact, partially offset by slightly lower sales volumes, lower realized silver and gold prices, lower income tax expense and exchange loss on translation to US Dollars.
Operating cash flows were down 41% to $7.2 million ($0.08 per share), from $12.2 million ($0.14 per share) primarily due to lower realized silver and gold prices and more gold deliveries into the Hedging Facility. The realized price of silver sales and gold spot sales were down 12% and 4% respectively. SilverCrest accelerated gold deliveries into the Hedging Facility, 4,210 ounces were delivered into the Hedging Facility during Q2 compared with 1,359 ounces in the previous quarter.
The financial information in this news release should be read in conjunction with the Company's unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2012 and associated MD&A which are available on the Company's website at www.silvercrestmines.com and under the Company's profile on SEDAR at www.sedar.com .
NON-IFRS PERFORMANCE MEASURES
The discussion of financial results in this press release includes reference to cash operating cost per silver equivalent ounce sold, which is a non-IFRS performance measure. The Company uses this measure to provide additional information regarding the Company's financial results and performance. Please refer to the Company's MD&A for the three and six months ended June 30, 2012, for a reconciliation of this measure to reported IFRS results.
OUTLOOK FOR REMAINDER OF 2012
SilverCrest's immediate focus is to continue to efficiently operate its flagship Santa Elena low cost open pit silver and gold mine, realize the full potential and value of the Santa Elena mine by executing the three year expansion plan to double metals production, and to rapidly advance the delineation of our major polymetallic deposit at the La Joya Property. Specific targets for H2, 2012 are as follows:
Santa Elena Open Pit Production
  • Meet or exceed estimated 2012 production, 33,000 gold ounces and 435,000 silver ounces;
  • Maintain cash operating cost at or below plan of $8.20 per ounce silver equivalent sold (55:1 Ag:Au);
  • Maintain operating cash flow in excess of $2 million per month, based on current silver and gold prices
Santa Elena Expansion
  • Complete underground decline development of main ramp, approximately 550 metres complete with, 950 metres remaining;
  • Secure long lead time items for mill and initiate tank fabrication;
  • Drill Santa Elena along strike and depth to expand underground resources;
  • Complete Pre-Feasibility Study on Expansion Plan (underground and mill);
  • Complete Pre-Feasibility Study on Cruz de Mayo satellite deposit as part of the Expansion Plan;
  • Continue site and regional exploration for further discoveries;
La Joya Project
  • Complete Phase II 80 hole drilling program (15 core and 20 reverse circulation drill holes remaining);
  • Explore the Coloradito, Esperanza and Santo Nino targets which are adjacent to the MMT;
  • Complete further metallurgical test work to initially determine amenability and potential polymetallic recoveries for Ag, Cu, Au, Pb, Zn, W, Sn, and Mo;
  • Complete revised resource estimation using Phase II results by Q4 2012.
N. Eric Fier, CPG, P.Eng. and Chief Operating Officer for SilverCrest Mines Inc. and Qualified Person for this news release has reviewed and approved its contents.
SilverCrest Mines Inc. (SVL.V) (STVZF) operates in Mexico and is a low cost precious metals producer with its headquarters based in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, which is located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag:Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango, Mexico.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
J. Scott Drever, President
SILVERCREST MINES INC.
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
Disclaimer: Investorideas.com does not make stock recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Silvercrest Mines has compensated Investorideas for annual news publication and distribution and company profile: nine thousand seven hundred starting August 2012
More info: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Tuesday, August 14, 2012

Beverage Stock DC Brands (OTC: HRDN) Brings Former Coca-Cola (NYSE:KO) and Coors Veteran on Board to Drive H.A.R.D. Nutrition Brand

New York, New York - August 14, 2012 (Investorideas.com newswire) DC Brands International, Inc.,(OTCBB:HRDN) reported in June that Mr. Stephen Horgan, Brand Aspirations Founder and Former Coca-Cola (NYSE:KO) and Coors Veteran purchased controlling interest of DC Brands International, Inc. /dba/H.A.R.D. Nutrition.

Mr. Horgan said, "After spending the last month assessing the Company and its prospects, and seeking advice and counsel with my peers and colleagues in the industry about the H.A.R.D. Nutrition Brand, I became overwhelmingly encouraged with the feedback I was receiving. I am confident that not only is the health and nutrition conscious consumer waiting for a brand like H.A.R.D. Nutrition, but the retail industry is ready to provide it. This analysis, combined with the strong team already in place, led me to conclude and believe that we can develop H.A.R.D. Nutrition into a national innovative force in the functional beverage industry."
Full details:
http://finance.yahoo.com/news/dc-brands-international-inc-announces-193000323.html
About DC Brands International:
DC Brands International, a publicly traded company under the ticker symbol (HRDN), presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category.
For more information on DC Brands International, Inc. and its HARD Nutrition Functional Water Systems, visit its website at www.hardnutrition.com.
Read CFA commentary and research notes on HRDN
http://www.investorideas.com/CO/HRDN/news/2012/08141.asp
Read recent Q&A with Mr. Stephen Horgan
http://www.investorideas.com/CO/HRDN/news/2012/08101.asp
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on current expectations, estimates and projections of management. The Company intends for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the Company's future in the industry and the expected contribution of Mr. Horgan All forward-looking statements in this press release are made as of the date of this press release, and the Company assumes no obligation to update these forward-looking statements whether as a result of new information, future events or otherwise, other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. These uncertainties include, but are not limited to, our failure to successfully integrate our new management as well as other risks detailed in the Company's SEC reports, including the Company's Form 10-K and other filings. Copies of these filings are available at www.sec.gov.
CONTACT: Wade Brantley, wbrantley@dc-brands.com
Published at Investorideas.com Newswire
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
http://www.investorideas.com/About/Disclaimer.asp
Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
DC Brands is featured on Running Bull OTC for SMS alerts - sign up for the ap with your iphone or Android; Blackberry coming soon!
http://www.runningbullotc.com/
Contact HRDN: Wade Brantley
wbrantley@dc-brands.com
Contact Investorideas.com 800 665 0411